Back to RecallTracker
Health Canada Health products

Oridermyl: The dosage of Triamcinolone acetonide may be out of specification for the affected lots.

Issued November 28, 2024
Issue
The dosage of Triamcinolone acetonide may be out of specification for the affected lots.
Hazard description
Product safety
What to do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
Oridermyl
Reference
ID
RA-76603